Home Cart Sign in  
Chemical Structure| 328998-25-0 Chemical Structure| 328998-25-0
Chemical Structure| 328998-25-0
Product Citations

Alternative Products

Product Details of 4E1RCat

CAS No. :328998-25-0
Formula : C28H18N2O6
M.W : 478.45
SMILES Code : O=C(O)C1=CC=C(N2C(/C(C=C2C3=CC=CC=C3)=C\C4=CC=C(C5=CC=C([N+]([O-])=O)C=C5)O4)=O)C=C1
Synonyms :
eIF4E/eIF4G Interaction Inhibitor II
MDL No. :MFCD01931282

Safety of 4E1RCat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
HEK293T cells 30 µM 24 hours To investigate the effect of 4E1RCat on the CCHFV-NP-mediated translation mechanism, results showed that 4E1RCat failed to inhibit the translation of GFP reporter mRNA mediated by CCHFV-NP. PMC5512247
HT-1080 cells 10 μM 24 hours 4E1RCat significantly inhibited RSL3-induced growth inhibition in HT-1080 cells, indicating its anti-ferroptotic effect. PMC9588786
Calu-1 cells 10 μM 72 hours 4E1RCat significantly inhibited erastin- or RSL3-induced ferroptosis in Calu-1 cells over 72 hours. PMC9588786
PANC1 cells 10 μM 4E1RCat inhibited erastin- or RSL3-induced cell death in PANC1 cells. PMC9588786
HepG2 cells 10 μM 4E1RCat inhibited erastin- or RSL3-induced cell death in HepG2 cells. PMC9588786
MEF cells 10 μM 4E1RCat inhibited erastin- or RSL3-induced cell death in MEF cells. PMC9588786
Normal human fibroblast 40 µM 72 hours Test the effect of drugs on cell viability, found that the combination of Sal and 4E1RCat had minimal effect on normal cells PMC7317660
Melanoma cell line (with BRAF V600E mutation) 40 µM 72 hours Test the effect of drugs on cell viability, found that the combination of Sal and 4E1RCat significantly decreased melanoma cell viability PMC7317660
Melanoma cell line (without BRAF V600E mutation) 40 µM 72 hours Test the effect of drugs on cell viability, found that the combination of Sal and 4E1RCat significantly decreased melanoma cell viability PMC7317660
hACE2-HeLa cells 5 μM 48 hours To evaluate the inhibitory effect of 4E1RCat on SARS-CoV-2 replication, the results showed that 4E1RCat significantly inhibited viral replication. PMC8075810
H460 8.0-11.0 μM 48 hours 4E1RCat effectively inhibited the growth of NSCLC cell lines PMC7957206
A549 8.0-11.0 μM 48 hours 4E1RCat effectively inhibited the growth of NSCLC cell lines PMC7957206
H1299 8.0-11.0 μM 48 hours 4E1RCat effectively inhibited the growth of NSCLC cell lines PMC7957206

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
nude mice HT-1080 xenograft model intraperitoneal injection 40 mg/kg Every two days for four weeks IKE-mediated tumor suppression was weakened in the EIF4E-knockdown group but enhanced in the ALDH1B1-knockdown group, indicating that EIF4E promotes ferroptosis while ALDH1B1 inhibits it. PMC9588786
Nude mice Melanoma xenograft model Intraperitoneal injection 1 mg/kg Twice a week for four weeks Test the effect of drugs on melanoma xenograft tumor growth, found that the combination of Sal and 4E1RCat significantly inhibited tumor growth PMC7317660
Caenorhabditis elegans ST65 strain Liquid culture 200 μL, [YBS] =1 mg/mL Day 5, 7, 9, 10 minutes each time To evaluate the inhibitory effect and toxicity of 4E1RCat on the MAPK/ERK signaling pathway in C. elegans. Results showed that 4E1RCat formed autofluorescent precipitates at 10 μM, precluding further analysis. PMC11409438
Mice AR- APIPC xenograft model Intraperitoneal injection 10 μM Twice daily for 2 weeks To evaluate the effect of 4E1RCat on tumor growth and survival in AR- prostate cancer PMC6746573
nude mice H460 NSCLC xenograft model intraperitoneal injection 15 mg/kg 5 times per week, continuous treatment 4E1RCat significantly repressed H460 tumor growth PMC7957206

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.09mL

0.42mL

0.21mL

10.45mL

2.09mL

1.04mL

20.90mL

4.18mL

2.09mL

References

 

Historical Records

Categories